InsidersTradesSigma
Total declarations
Company
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
9
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.7%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Flowers Lee. Officer active across 1 company, notably HCW Biologics Inc.. In total, 14 filings have been logged. Split: 9 buys · 0 sell. Total volume traded: €656k. History available since 22 July 2021. The latest transaction was filed on 8 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
962 shares@ US$26.003.0% of flowCommon StockSEC:0000950170-25-068275:0
Ideal exit: 2 Feb 2026 (T+270)
71,429 shares@ US$1.4012.3% of flowCommon StockSEC:0001209191-24-003783:0
7,501 shares@ US$0.140.1% of flowCommon StockSEC:0001209191-23-058081:0
5,356 shares@ US$0.140.1% of flowCommon StockSEC:0001209191-23-036087:0
4,285 shares@ US$0.140.1% of flowCommon StockSEC:0001209191-21-067740
4,285 shares@ US$0.140.0064% mcap0.1% of flowCommon StockSEC:0001209191-21-067740:0
10,532 shares@ US$4.29340.47% mcap6.1% of flowCommon StockSEC:0001209191-21-053163:0
Ideal exit: 16 May 2022 (T+270)
7,853 shares@ US$4.08370.33% mcap4.3% of flowCommon StockSEC:0001209191-21-053170:0
Ideal exit: 17 May 2022 (T+270)
10,532 shares@ US$4.29345.2% of flowCommon StockSEC:0001209191-21-053163
Ideal exit: 16 May 2022 (T+270)
7,853 shares@ US$4.08373.7% of flowCommon StockSEC:0001209191-21-053170
Ideal exit: 17 May 2022 (T+270)
10,532 shares@ US$4.25230.47% mcap6.0% of flowCommon StockSEC:0001209191-21-053050:0
Ideal exit: 16 May 2022 (T+270)
10,532 shares@ US$4.25235.1% of flowCommon StockSEC:0001209191-21-053050
Ideal exit: 16 May 2022 (T+270)
31,250 shares@ US$8.0028.3% of flowCommon StockSEC:0001209191-21-048080
Ideal exit: 18 Apr 2022 (T+270)
31,250 shares@ US$8.002.58% mcap33.4% of flowCommon StockSEC:0001209191-21-048080:0
Ideal exit: 18 Apr 2022 (T+270)
14 of 14 declarations
About Flowers Lee
Flowers Lee is a director at HCW Biologics Inc.
